Fighting Inflammation and Alzheimer’s – Dr. David Bearss on BioTech Nation podcast
March 21, 2024

March 20, 2024/28:57/E24012

In this episode of BioTech Nation, Dr. David Bearss, President, and CEO of Halia Therapeutics, discusses inflammation and its reduction over a lifetime and in response to various incidents. He unveils the inflammasome, a recently discovered protein complex critical in regulating inflammatory responses, and its potential in treating chronic diseases like myelodysplastic syndrome and Alzheimer’s. Dr. Bearss shares insights into Halia’s groundbreaking approach and his relentless pursuit of medical breakthroughs.